Infantile herpangina
Conditions
Interventions
Western medicine control group:Human recombinant interferon alpha 2 b sprays
Acupuncture group:Stab winding bleeding
Sponsors
Baoshan District Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Shanghai
Eligibility
Sex/Gender
All
Age
1 Years to 7 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria for pediatric herpetic pharyngitis in Western medicine. 2. Age 1-7 years old. 3. The course of the disease is less than 3 days. 4. The nucleic acid test of novel coronavirus pneumonia was negative. 5. The guardian has informed consent, the child cooperates with treatment, and signs an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with concomitant heart, liver, and kidney dysfunction, impaired coagulation mechanisms, and complications. 2. Individuals who are allergic to Western medicine in this study. 3. Needle sickness. 4. Patients with skin inflammation or damage at acupoints. 5. Children with herpes on their hands and feet, or diagnosed with hand, foot, and mouth disease. 6. Individuals with spontaneous bleeding or coagulation disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical curative effect;Clinical symptom relief time (including time for herpes to dissipate, time for sore throat to disappear, time for fever to subside, time for appetite improvement, time for salivation to disappear, etc.);Total duration of disease; | — |
Secondary
| Measure | Time frame |
|---|---|
| Relevant laboratory indicators; | — |
Countries
China
Contacts
Public ContactYao JunLi
Baoshan District Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Shanghai
Outcome results
None listed